5MinuteHematology

Polatuzumab Vedotin + Bendamustine + Rituximab (Pola-BR) Protocol

Curated Five Minute Hematology reference for Polatuzumab Vedotin + Bendamustine + Rituximab (Pola-BR). Open the approved protocol in 5MH Tools.

Lymphoma Treatment regimen

Open protocol

Continue to the reviewed 5MH Tools protocol reference for regimen details, schedule, supportive-care context, evidence and source transparency.

Open protocol All 5MH Tools
Protocol reference Polatuzumab Vedotin + Bendamustine + Rituximab (Pola-BR) · Lymphoma · Treatment regimen · v1.0.1
Aliases Pola-BR, Pola BR, Polatuzumab-BR
Medical review Reviewed 2026-10-07 · 6 cycles; every 21 days
Protocol type Defined multi-drug regimen with a specified treatment schedule.
Source transparency Evidence references are available in the approved 5MH protocol.
For qualified healthcare professionals · Educational and professional reference use only · Verify clinically relevant information against original sources